GLP-1 and Exendin-4 Transiently Enhance GABAA Receptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a hormone that stimulates insulin secretion. Receptors for GLP-1 are also found in the brain, including the hippocampus, the center for memory and learning. Diabetes is a risk factor for decreased memory functions. We studied effects of GLP-1 and exendin-4, a GLP-1 receptor agonist, on γ-aminobutyric acid (GABA) signaling in hippocampal CA3 pyramidal neurons. GABA is the main inhibitory neurotransmitter and decreases neuronal excitability. GLP-1 (0.01–1 nmol/L) transiently enhanced synaptic and tonic currents, and the effects were blocked by exendin (9-39). Ten pmol/L GLP-1 increased both the spontaneous inhibitory postsynaptic current (sIPSC) amplitudes and frequency by a factor of 1.8. In 0.1, 1 nmol/L GLP-1 or 10, 50, or 100 nmol/L exendin-4, only the sIPSC frequency increased. The tonic current was enhanced by 0.01–1 nmol/L GLP-1 and by 0.5–100 nmol/L exendin-4. When action potentials were inhibited by tetrodotoxin (TTX), inhibitory postsynaptic currents decreased and currents were no longer potentiated by GLP-1 or exendin-4. In contrast, although the tonic current decreased in TTX, it was still enhanced by GLP-1 or exendin-4. The results demonstrate GLP-1 receptor regulation of hippocampal function and are consistent with GLP-1 receptor agonists enhancing GABAA signaling by pre- and postsynaptic mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although GLP-1R stimulation has been shown to modulate GABAergic signaling in the hippocampus and NTS (38–40), the effects of GLP-1R agonism on GABAergic synapses in the CeA and ILC, especially in the context of alcohol drinking, are unknown.”
From The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission (2023) · cites this paper as [38]
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 7×
“Initially, the peptide GLP-1 (1-37) was identified from this processing, but later it was shown that there were two shorter peptides, GLP-1 (7-37) and GLP-1 (7-36)amide, that were the active species in vivo.”
BackgroundMethodInfluentialThe three-dimensional organization of the hippocampal formation: A review of anatomical data
Amaral, D. G., & Witter, M. P. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90424-7 · Cited by 2,180 · cited 1×
“Both the CA3 and the CA1 neurons have critical roles in hippocampal-dependent memory and learning processes (43).”
BackgroundVariations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodInfluentialThe role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodInfluentialTonically active GABAA receptors: modulating gain and maintaining the tone
Semyanov, A., Walker, M. C., Kullmann, D. M., & Silver, R. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.005 · Cited by 743 · cited 8×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluentialMojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551 · cited 1×
“Initially, the peptide GLP-1 (1-37) was identified from this processing, but later it was shown that there were two shorter peptides, GLP-1 (7-37) and GLP-1 (7-36)amide, that were the active species in vivo.”
BackgroundRecruitment of functional GABAA receptors to postsynaptic domains by insulin
Wan, Q., Xiong, Z. G., Man, H. Y., Ackerley, C. A., Braunton, J., Lu, W. Y., Becker, L. E., MacDonald, J. F., & Wang, Y. T. (1997) · Nature · doi:10.1038/41792 · Cited by 537 · cited 8×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluential
Cited by
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
“GABA receptors to postsynaptic membranes [29,30].”
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
“170671 field, showing increased GABAergic signaling in the hypothalamus (103) and hippocampus (38, 104, 105) of alcohol-naive rodents after treatment with GLP-1 or other GLP-1 analogues, which might be linked to increased intracellular cAMP levels after GLP-1R activation (39, 106, 107).”
Liu, J., Conde, K., Zhang, P., Lilascharoen, V., Xu, Z., Lim, B. K., Seeley, R. J., Zhu, J. J., Scott, M. M., & Pang, Z. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.042 · Cited by 190
“…profound effects on synaptic transmission (for review see: Liu and Pang, 2016), however, the intracellular signaling cascades and pre- or postsynaptic site of action appear to be dependent on brain region and cell type (Acuna-Goycolea and van den Pol, 2004; Korol et al., 2015; Wang et al., 2015).”
Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 158
“Furthermore, insulin is implicated in the recruitment of the GABA (gamma-aminobutyric acid) receptor to the postsynaptic membrane, thus regulating inhibitory synapses [28,59,70,80,81].”
BackgroundGault, V. A., Lennox, R., & Flatt, P. R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12432 · Cited by 141
“The precise mechanisms underlying the positive actions of GLP-1 receptor agonists on cognition are not yet known, but evidence points towards improved hippocampal synaptic plasticity and reduced GABAA receptor-mediated synaptic and tonic currents in CA3 pyramidal neurons [41,53].”
Metadata
- Authors
- Korol, S. V., Jin, Z., Babateen, O., & Birnir, B.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Birnir, Bryndis
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-08-11
- Volume
- 64
- Issue
- 1
- Pages
- 79-89
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2161146234
- Cited by
- 101
- References
- 52
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 7 · 2020: 10 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 10 · 2015: 7
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- urn.kb.se
- Licence
- other-oa
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucagon-like peptide-1, exendin-4, GLP-1 receptor, GABAA receptor, hippocampal CA3 pyramidal neurons, inhibitory postsynaptic currents, tonic inhibition, GABA signaling, exendin-9-39, tetrodotoxin, synaptic inhibition
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, gamma-Aminobutyric Acid, Membrane Potentials, Memory, Synaptic Transmission, Organ Culture Techniques, Peptides, Receptors, GABA-A, Tetrodotoxin, Venoms, Signal Transduction, Rats, Wistar, Pyramidal Cells, Receptors, Glucagon, Patch-Clamp Techniques, Sodium Channel Blockers, Glucagon-Like Peptide 1, Inhibitory Postsynaptic Potentials, CA3 Region, Hippocampal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GLP-1 and Exendin-4 Transiently Enhance GABAA Receptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons. https://app.cochat.ai/papers/10.2337/db14-0668
- The paper
- Korol, S. V., Jin, Z., Babateen, O., & Birnir, B. (2015). GLP-1 and Exendin-4 Transiently Enhance GABAA Receptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons. Diabetes. https://doi.org/10.2337/db14-0668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.